These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors. Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488 [TBL] [Abstract][Full Text] [Related]
64. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. Viard JP; Burgard M; Hubert JB; Aaron L; Rabian C; Pertuiset N; Lourenço M; Rothschild C; Rouzioux C AIDS; 2004 Jan; 18(1):45-9. PubMed ID: 15090828 [TBL] [Abstract][Full Text] [Related]
66. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. Metcalf Pate KA; Pohlmeyer CW; Walker-Sperling VE; Foote JB; Najarro KM; Cryer CG; Salgado M; Gama L; Engle EL; Shirk EN; Queen SE; Chioma S; Vermillion MS; Bullock B; Li M; Lyons CE; Adams RJ; Zink MC; Clements JE; Mankowski JL; Blankson JN J Infect Dis; 2015 Nov; 212(9):1387-96. PubMed ID: 25883388 [TBL] [Abstract][Full Text] [Related]
67. Brief Report: Identification of Elite and Viremic Controllers From a Large Urban HIV Ambulatory Center in Kampala, Uganda. Kayongo A; Gonzalo-Gil E; Gümüşgöz E; Niwaha AJ; Semitala F; Kalyesubula R; Bagaya BS; Joloba ML; Sutton RE J Acquir Immune Defic Syndr; 2018 Nov; 79(3):394-398. PubMed ID: 30063647 [TBL] [Abstract][Full Text] [Related]
68. HIV-1 DNA burden in peripheral blood CD4+ cells influences disease progression, antiretroviral efficacy, and CD4+ T-cell restoration. Russell RR; Bowmer MI; Nguyen C; Grant MD Viral Immunol; 2001; 14(4):379-89. PubMed ID: 11792067 [TBL] [Abstract][Full Text] [Related]
69. "Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy. Wood E; Hogg RS; Yip B; Tyndall MW; Sherlock CH; Harrigan RP; O'Shaughnessy MV; Montaner JS J Acquir Immune Defic Syndr; 2002 Jun; 30(2):159-66. PubMed ID: 12045678 [TBL] [Abstract][Full Text] [Related]
70. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression. Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735 [TBL] [Abstract][Full Text] [Related]
71. High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses. Arias JF; Nishihara R; Bala M; Ikuta K Retrovirology; 2010 Mar; 7():15. PubMed ID: 20211031 [TBL] [Abstract][Full Text] [Related]
72. MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients. Moghoofei M; Najafipour S; Mostafaei S; Tavakoli A; Bokharaei-Salim F; Ghorbani S; Javanmard D; Ghaffari H; Monavari SH Curr HIV Res; 2021; 19(1):27-34. PubMed ID: 32900348 [TBL] [Abstract][Full Text] [Related]
73. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505 [TBL] [Abstract][Full Text] [Related]
74. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. Tamalet C; Lafeuillade A; Fantini J; Poggi C; Yahi N AIDS; 1997 Jun; 11(7):895-901. PubMed ID: 9189215 [TBL] [Abstract][Full Text] [Related]
75. Expression profile of host restriction factors in HIV-1 elite controllers. Abdel-Mohsen M; Raposo RA; Deng X; Li M; Liegler T; Sinclair E; Salama MS; Ghanem Hel-D; Hoh R; Wong JK; David M; Nixon DF; Deeks SG; Pillai SK Retrovirology; 2013 Oct; 10():106. PubMed ID: 24131498 [TBL] [Abstract][Full Text] [Related]
76. HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression. Kammers K; Chen A; Monaco DR; Hudelson SE; Grant-McAuley W; Moore RD; Alter G; Deeks SG; Morrison CS; Eller LA; Blankson JN; Laeyendecker O; Ruczinski I; Eshleman SH; Larman HB Front Immunol; 2021; 12():740395. PubMed ID: 34512672 [TBL] [Abstract][Full Text] [Related]
77. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036 [TBL] [Abstract][Full Text] [Related]
78. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273 [TBL] [Abstract][Full Text] [Related]
79. CD4 T-cell regeneration in HIV-1 elite controllers. Yang Y; Al-Mozaini M; Buzon MJ; Beamon J; Ferrando-Martinez S; Ruiz-Mateos E; Rosenberg ES; Pereyra F; Yu XG; Lichterfeld M AIDS; 2012 Mar; 26(6):701-6. PubMed ID: 22301416 [TBL] [Abstract][Full Text] [Related]